Full-Time

Material Control Specialist 2

Curia

Curia

1,001-5,000 employees

End-to-end drug development and manufacturing

No salary listed

No H1B Sponsorship

Springfield, MO, USA

In Person

Category
Operations & Logistics (1)
Requirements
  • High school diploma or equivalent
  • Minimum 3-5 years’ relevant experience
  • Ability to communicate directly with customers to ensure no issues with shipments occurs
  • Attention to detail
  • Willingness to work with chemicals
  • Good written and verbal communication skills and ability to coordinate a number of diverse responsibilities
  • Ability to set up all paperwork for material being shipped
  • Perform all GMP related documentation in compliance with ALCOA and good documentation practices as defined by site Standard Operating Procedures
  • Strict compliance with all current Good Manufacturing Practices and cGMP documents
  • Ensure all cGMP applicable training is kept current
  • Do not perform any cGMP task for which you have not received appropriate training
  • Escalate any cGMP concerns to Supervisors and to Quality Department as needed
  • Perform job functions in compliance with applicable United States Food and Drug Administration regulations and current Good Manufacturing Practices
  • Work prioritization or timing decisions with supervisory oversight
  • Set up sample shipments to be sent out for testing
  • Set up all paperwork for material being shipped, including Bill of Lading, Safety Data Sheet, Certificate of Analysis, packing list, commercial invoice, hazardous material shipper etc.
  • Generate applicable Good Manufacturing Practice paperwork for the material
  • Utilize the chemical inventory database for non-Good Manufacturing Practice materials
  • Maintain excellent documentation skills, safety practices and thorough knowledge of GMP and non-GMP policies
  • Utilize metric system for mass and volume and be physically able to perform the duties of the position
  • Participate in cross-training, self-development activities and training of others
  • Exhibit safety awareness and safe work practices
  • Recommend and implement methods to increase the quality of products and/or services, cost reduction and safety opportunities
  • Comply with all Curia Standard Operating Procedures, safety guidelines and applicable regulatory guidelines
Responsibilities
  • Utilize MRP with the site Enterprise Resource Planning system to maintain accurate inventory levels to meet the manufacturing schedule, and Sales plan
  • Lead the cycle counting process for the site (creation, execution, and reconciliation)
  • Handle the tracking and disposal of expired materials
  • Handle controlled substance shipments. This included completing DEA form 222s, filing controlled substance shipment paperwork, communicating with Curia personnel to have accurate counts on shipments and communicating directly with customers with any issues with DEA Form 222.
  • Provide documentation and communication with multiple carriers to ship exports and receive imports
  • Communicate key documents for Air and Ocean shipments (ISF) to our couriers to ensure no violations are had
  • Utilize software to submit and handle all import and export documents electronically to key parties, including Customs, to keep track of each shipment and maintain accurate inventory levels in that system
  • Communicate with customer service to ensure no issues with shipments occurs. Customer Service will communicate directly with the customer.
  • Maintain accurate inventory levels and communicate with manufacturing & sales on what is needed to be repacked to fit Sales orders to accurately ship material
  • Manage the material requests and create kitting forms for all production buildings and communicate to production any issues with materials in a non-transferrable status
  • Initiate processes which communicate expectations and deadlines to buildings about when to submit requests to allow for proper time to get material to production buildings
  • Set up sample shipments to be sent out for testing
  • Set up all paperwork for material being shipped, including BOL, SDS, C of A, packing list, commercial invoice, HAZ shipper etc.
  • Generate applicable GMP paperwork for the material
  • Utilize the chemical inventory database for non-GMP materials
  • Maintain excellent documentation skills
  • Participation in cross-training and training of others
  • Exhibit safety awareness and safe work practices
  • Recommend and implement methods to increase the quality of products and/or services, cost reduction and safety opportunities
  • Comply with all Curia SOPs, safety guidelines and applicable regulatory guidelines
Desired Qualifications
  • Bachelor’s degree in a relevant field
  • Previous warehouse or pharmacy experience

Curia is a contract development and manufacturing organization (CDMO) that partners with pharmaceutical and biotech companies to move medical breakthroughs from concept to market. It provides end-to-end services across the drug development lifecycle, including early research, method development and validation, preformulation, material science, solid-state chemistry, and package device testing. Revenue comes from service contracts for specialized capabilities and expertise, with clients ranging from small startups to large pharma. Curia also collaborates with industry leaders to advance continuous flow development and manufacturing programs. The company differentiates itself through flexible and scalable solutions, deep scientific expertise, and state-of-the-art technology that help clients accelerate development timelines while navigating discovery to commercialization. Its goal is to enable efficient, reliable progression of drug candidates from conception through to market approval.

Company Size

1,001-5,000

Company Stage

Debt Financing

Total Funding

$1.1B

Headquarters

Albany, New York

Founded

1991

Simplify Jobs

Simplify's Take

What believers are saying

  • Biologics segment expansion under Steve Lavezoli accelerates high-margin pharmaceutical outsourcing revenue growth.
  • Carterra partnership positions Curia to capture Pacific Northwest biotech demand in antibody discovery services.
  • Gerald Auer's CFO appointment signals M&A activity and potential strategic initiatives enhancing shareholder value.

What critics are saying

  • Pace Life Sciences acquisition of New Jersey lab erodes Curia's analytical testing capacity and revenue.
  • Larger CDMOs like Lonza and Catalent undercut Curia on biologics capacity, stealing biotech contracts.
  • FDA scrutiny on srRNA manufacturing defects from Replicate Bioscience Phase 1 triggers potential client exodus.

What makes Curia unique

  • Pioneer in self-replicating RNA manufacturing, demonstrated through Replicate Bioscience Phase 1 clinical trial support.
  • Integrated enzymatic doggybone DNA technology via Touchlight collaboration expands mRNA manufacturing competitive advantages.
  • End-to-end CDMO services from discovery through cGMP manufacturing differentiate Curia from specialized competitors.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Curia who can refer or advise you

Benefits

Paid Vacation

401(k) Retirement Plan

401(k) Company Match

Tuition Reimbursement

Professional Development Budget

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
The Carlyle Group
Jan 30th, 2026
AMRI Announces Completion of Acquisition by The Carlyle Group and GTCR | Carlyle

ALBANY, N.Y. – Albany Molecular Research, Inc. (NASDAQ:AMRI), a global contract research, development and manufacturing organization working with the life sciences industry to improve patient outcomes and quality of life for more than 25 years, today announced the completion of its previously announced acquisition by affiliates of The Carlyle Group (“Carlyle”) and affiliates of GTCR LLC (“GTCR”). President and Chief Executive Officer William S. Marth will continue to lead AMRI.

BERNAMA
May 10th, 2024
BIOLOGICS SYMPOSIUM: CURIA, CARTERRA PARTNER TO ADVANCE BIOTECH RESEARCH IN PACIFIC NORTHWEST

KUALA LUMPUR, May 10 (Bernama) - Curia, a contract research, development and manufacturing organisation (CDMO) has announced a partnership with Carterra Inc in hosting a high-throughput biologics symposium slated for May 31, in Seattle, Washington.

PharmiWeb.com
Mar 14th, 2024
Pace® Life Sciences Acquires New Jersey Laboratory From Curia

Former Whitehouse Analytical Laboratory is Now Part of the Pace® Laboratory Network

PPI News Agency
Feb 23rd, 2024
Curia Appoints Steve Lavezoli as Vice President, Biologics

ALBANY, N.Y., Feb. 23, 2024 (GLOBE NEWSWIRE) - Curia, a leading contract research, development and manufacturing organization, today announced it has appointed Steve Lavezoli as vice president of biologics effective Feb. 26.

Cameroon Online News
Feb 5th, 2024
Curia Receives 2024 CDMO Leadership Award

Curia was awarded based on the feedback of respondents in the Small Pharma category.